コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 resent a formidible challenge throughout the perioperative period.
2 ully cleared of synchronous neoplasia in the perioperative period.
3 entional echocardiographic techniques in the perioperative period.
4 evaluate the role that xenon can play in the perioperative period.
5 osophy of management is being applied to the perioperative period.
6 s are studies relating to anesthesia and the perioperative period.
7 rugs can markedly enhance pain relief in the perioperative period.
8 inuance, or initiation of medications in the perioperative period.
9 mia should be maintained strictly during the perioperative period.
10 ably high mortality and morbidity during the perioperative period.
11 candidates for IV amiodarone therapy in the perioperative period.
12 unction in the NHBD renal transplants in the perioperative period.
13 dications that may pose a concern during the perioperative period.
14 nts and aggressive medical management in the perioperative period.
15 a new protocol for administering DSTs in the perioperative period.
16 tenosis that may predispose to stroke in the perioperative period.
17 blunting the stress response throughout the perioperative period.
18 the neurologic status of the patient in the perioperative period.
19 One patient died in the perioperative period.
20 ifferent patient population to manage in the perioperative period.
21 e personalized management of patients in the perioperative period.
22 tant cause of morbidity and mortality during perioperative period.
23 se interventions were appropriate during the perioperative period.
24 No adverse events were reported during the perioperative period.
25 0.04), once the TGA patient has survived the perioperative period.
26 tracorporeal membrane oxygenation during the perioperative period.
27 be treated with low doses of steroids in the perioperative period.
28 f ischemic and bleeding complications in the perioperative period.
29 required to sustain tissue perfusion in the perioperative period.
30 eive a higher level of monitoring during the perioperative period.
31 a high risk for acute decompensation in the perioperative period.
32 received belatacept immunosuppression in the perioperative period.
33 d continue their maintenance dose during the perioperative period.
34 ave reduced IP 5-HT levels during the entire perioperative period.
35 uld be avoided in orthopedic patients in the perioperative period.
36 and limit morbidity and mortality during the perioperative period.
37 f care ultrasound and its utilization in the perioperative period.
38 als, and their functions are relevant in the perioperative period.
39 doses or low doses of corticosteroids in the perioperative period.
40 gh-risk situations and prevent errors in the perioperative period.
41 tive measures of nociception and pain in the perioperative period.
42 gram), and group 4 received treatment in the perioperative period.
43 likewise likely to also be important in the perioperative period.
44 es to the anesthesiologist during the entire perioperative period.
45 have their aspirin continued throughout the perioperative period.
46 utcomes than open colectomy in the immediate perioperative period.
47 ilure (ALF) present unique challenges in the perioperative period.
48 mologists do prescribe an antibiotic for the perioperative period.
49 complications extends well after the initial perioperative period.
50 ens to reduce reliance on opioids during the perioperative period.
51 ortunities, and improved patient care in the perioperative period.
52 the many drugs that are administered in the perioperative period.
53 ose should be continued daily throughout the perioperative period.
54 (7%), and 38 deaths (9%) recorded during the perioperative period.
55 3.3 to 1.4); most deaths occurred during the perioperative period.
56 on occurred in 7%, the majority (57%) in the perioperative period.
57 conditioning agents, particularly during the perioperative period.
58 significant anxiety and distress during the perioperative period.
59 ial carbon dioxide tension management in the perioperative period.
60 significant challenges in the operative and perioperative periods.
61 asma clonidine concentrations throughout the perioperative period (1.54 +/- .07 [SEM] microg/mL).
66 possible, aspirin should be continued in the perioperative period, although the management of P2Y(1)(
67 se, 19 (2.0%) occurred during the intra- and perioperative period and 44 were late complications (4.7
68 uria and antimicrobial initiation during the perioperative period and assess harms versus benefits of
69 ients with lung cancer were drawn during the perioperative period and assessed for CTC burden using a
70 challenges encountered by LT patients in the perioperative period and how these responses can be exac
71 n the implementation of physiotherapy in the perioperative period and its enhancement of postsurgical
72 be maintained on anticoagulation during the perioperative period and may not need thrombolysis prior
73 (IRI) is a major clinical problem during the perioperative period and occurs frequently after major h
74 on the role of diastolic dysfunction in the perioperative period and on recent advances in the diagn
75 p also received a mean of 2.3 U blood in the perioperative period and showed a trend to increased sym
76 oid analgesic use should be optimized in the perioperative period, and (3) patient and family educati
77 ies in electroencephalogram (EEG) during the perioperative period, and new stratification schemata.
78 wel disease, patient blood management in the perioperative period, and obstetrics and gynaecology.
79 ch as unusual site thrombosis, bleeding, the perioperative period, and pregnancy, are especially chal
80 pressure ulcers is rarely identified in the perioperative period, and the influence of this period o
81 The majority (70%) of events occurred in the perioperative period, and the occurrence of a CV event w
83 on the use of VEGF-targeted therapies in the perioperative period are sparse, and investigators are u
85 and caloric requirements for children in the perioperative period before and after cardiac surgery an
86 tus (cerebrovascular resistance), during the perioperative period (brain biomarkers and EEG), and thr
87 excess risk in the surgical group during the perioperative period but lower risk after that compared
93 idespread use of beta-blocker therapy in the perioperative period, especially because such therapy mi
94 (i) whether the improvements observed in the perioperative period fluctuate or remain stable 10 years
95 issues surrounding the use of opioids in the perioperative period, focusing on drivers that led to es
96 art of decision-making and monitoring in the perioperative period for patients undergoing valvular he
98 utcome was WHO grade 3 bleeding in the early perioperative period (from entry into the operating room
99 ed concentration of oxygen (FIO2) during the perioperative period has been reported to be of benefit
104 ncreased risk for patient death, both in the perioperative period (hazard ratio 3.20, 95% confidence
105 ients were prescribed benzodiazepines in the perioperative period; however, 1 in 5 of these patients
108 dications should be continued throughout the perioperative period in ambulatory surgical patients.
109 may also have important implications in the perioperative period, in which the use of novel oral ant
110 interactions that are most important in the perioperative period include sympathomimetic, sedative,
111 higher rates of medical complications in the perioperative period, including acute renal failure (sub
112 bined with transfusion of donor cells in the perioperative period interrupts sensitization and may pr
116 management of these patients throughout the perioperative period is essential to ensure an optimal s
117 to comorbidities and their management in the perioperative period is increasingly important as older
118 he evidence for nutrition support during the perioperative period is reviewed and recommendations are
120 anagement of such hormone therapy during the perioperative period is unknown and without clear guidel
121 ion of a high-quality service throughout the perioperative period is vital for a successful outcome.
122 nal IRI is a devastating complication in the perioperative period leading to systemic inflammation an
124 ical properties of drugs administered in the perioperative period may assist in their deliberate use
125 opriately addressing these issues during the perioperative period may improve the rate of endothelial
127 nous administration of esketamine during the perioperative period of elective cesarean delivery can i
128 essary to improve cardiovascular care in the perioperative period of patients undergoing noncardiac s
129 d with systemic TGF-beta blockade during the perioperative period of primary tumor resection, to conf
133 red oxygen concentration (FiO(2)) during the perioperative period on the incidence of surgical site i
134 If buprenorphine is continued during the perioperative period, patients may require significantly
135 vaccination against authentic Ags during the perioperative period provides long-lasting protection ag
137 ing for patients with coronary stents in the perioperative period requires input from a team consisti
138 An appreciation for the challenges in the perioperative period requires the joint efforts of physi
140 s caring for children and adolescents in the perioperative period should optimize pain management and
141 withdrawal, which are exacerbated during the perioperative period, standard practice has been to stop
142 s evaluating beta-blocker therapy during the perioperative period suggested that beta-blockers may be
144 sfusion is justified for patients during the perioperative period, those with coronary artery disease
145 Future studies are needed throughout the perioperative period to identify interventions that will
147 nsfusions and use all means available in the perioperative period to optimize the patients and avoid
148 nts, use of anticoagulation in the immediate perioperative period to prevent thromboembolic complicat
150 ed preventative strategies to be used in the perioperative period to reduce complications and costs a
152 ot have systemic metastases and survived the perioperative period were assessed by multivariate analy
153 The majority of patient deaths after the perioperative period were not attributable to right vent
154 not receive antilymphocyte antibodies in the perioperative period were selected if individual patient
155 ological therapy during the preoperative and perioperative periods were evaluated in association with
156 gery generally experience anxiety during the perioperative period, which could impact the surgical ou
157 Transfusion rates were calculated for the perioperative period, which was defined as the time from
158 mation and enhancing NK cell function in the perioperative period will have important clinical implic
159 an updated review on the role of NETs in the perioperative period with specific emphasis on periopera
160 s the use of potent immunosuppression in the perioperative period with the intent to diminish rejecti
161 rt course of potent immunosuppression in the perioperative period, with the goal of preventing early